House Appropriation Draft Gives FDA $167 Million Boost

The House Appropriations Committee has released a draft fiscal year (FY) 2020 spending bill that would provide $5.85 billion for FDA — $167 million more than FY 2019 enacted budget, but $252 million (4%) less than the $6.1 the Trump Administration proposed earlier this year. The bill provides for $3.26 billion in discretionary funding and about $2.6 billion in user fee revenue.

A summary of the measure says the “Committee provides target increases for medical product and food safety activities, including new initiatives to revolutionize the safety of the nation’s blood supply and to enable faster responses to foodborne illness outbreaks. In addition, the bill includes a strong focus on continuing FDA’s efforts to advance generic drug reviews and increase medical product manufacturing in the U.S. The bill also appropriates $75 million to accelerate medical product development as authorized in the 21st Century Cures Act.”